COVID-19 Australia: Epidemiology Report 35 Reporting period ending 14 February 2021
DOI:
https://doi.org/10.33321/cdi.2021.45.9Keywords:
SARS-CoV-2, novel coronavirus, 2019-nCoV, coronavirus disease 2019, COVID-19, acute respiratory disease, epidemiology, AustraliaAbstract
Trends – Australia continues to report low numbers of COVID-19 cases. The daily average number of cases for this reporting period was five compared to an average of six cases per day in the previous fortnight. There were 69 cases of COVID-19 and no deaths this fortnight, bringing the cumulative case count to 28,868 with 909 deaths.
Downloads
References
COVID-19 National Incident Room Surveillance Team. COVID-19 Australia: Epidemiology Report 34: Fortnightly reporting period ending 31 January 2021. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.8.
COVID-19 National Incident Room Surveillance Team. Technical supplement: COVID-19 Australia: epidemiology reporting. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.2.
Global Initiative on Sharing All Influenza Data (GISAID). [Website.] Berlin: Federal Republic of Germany, Freunde von GISAID e.V.; 2020. [Accessed on 20 January 2021.] Available from: https://www.gisaid.org/.
Rockett RJ, Arnott A, Lam C, Sadsad R, Timms V, Gray KA et al. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling. Nat Med. 2020. doi: https://doi.org/10.1038/s41591-020-1000-7.
Seemann T, Lane CR, Sherry NL, Duchene S, Goncalves da Silva A, Caly L et al. Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020;11(1):4376. doi: https://doi.org/10.1038/s41467-020-18314-x.
Eden JS, Rockett R, Carter I, Rahman H, de Ligt J, Hadfield J et al. An emergent clade of SARS-CoV-2 linked to returned travellers from Iran. Virus Evol. 2020;6(1):veaa027. doi: https://doi.org/10.1093/ve/veaa027.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
